Tailoring B cell depletion therapy in MS according to memory B cell monitoring

Abstract

This study provides Class IV evidence that for patients with MS, a memory B cell-based RTX reinfusion protocol can reduce the mean number of RTX reinfusions with persistent reduction of disease activity.